• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

面对锥虫寄生虫引起的疾病:具有生物活性配体的钯和铂配合物的合理设计。

Facing Diseases Caused by Trypanosomatid Parasites: Rational Design of Pd and Pt Complexes With Bioactive Ligands.

作者信息

Gambino Dinorah, Otero Lucía

机构信息

Área Química Inorgánica, DEC, Facultad de Química, Universidad de la República, Montevideo, Uruguay.

出版信息

Front Chem. 2022 Jan 7;9:816266. doi: 10.3389/fchem.2021.816266. eCollection 2021.

DOI:10.3389/fchem.2021.816266
PMID:35071192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8777014/
Abstract

Human African Trypanosomiasis (HAT), Chagas disease or American Trypanosomiasis (CD), and leishmaniases are protozoan infections produced by trypanosomatid parasites belonging to the kinetoplastid order and they constitute an urgent global health problem. In fact, there is an urgent need of more efficient and less toxic chemotherapy for these diseases. Medicinal inorganic chemistry currently offers an attractive option for the rational design of new drugs and, in particular, antiparasitic ones. In this sense, one of the main strategies for the design of metal-based antiparasitic compounds has been the coordination of an organic ligand with known or potential biological activity, to a metal centre or an organometallic . Classical metal coordination complexes or organometallic compounds could be designed as multifunctional agents joining, in a single molecule, different chemical species that could affect different parasitic targets. This review is focused on the rational design of palladium(II) and platinum(II) compounds with bioactive ligands as prospective drugs against trypanosomatid parasites that has been conducted by our group during the last 20 years.

摘要

人类非洲锥虫病(HAT)、恰加斯病或美洲锥虫病(CD)以及利什曼病是由属于动质体目的锥虫寄生虫引起的原生动物感染,它们构成了一个紧迫的全球健康问题。事实上,迫切需要针对这些疾病开发更高效、毒性更低的化疗方法。药用无机化学目前为合理设计新药,特别是抗寄生虫药物提供了一个有吸引力的选择。从这个意义上讲,设计基于金属的抗寄生虫化合物的主要策略之一是将具有已知或潜在生物活性的有机配体与金属中心或有机金属配位。经典的金属配位络合物或有机金属化合物可以设计为多功能试剂,在单个分子中结合不同的化学物种,这些物种可能作用于不同的寄生虫靶点。本综述聚焦于我们团队在过去20年中对具有生物活性配体的钯(II)和铂(II)化合物进行合理设计,作为对抗锥虫寄生虫的潜在药物的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a4/8777014/1c658651c16e/fchem-09-816266-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a4/8777014/17a282806d9d/fchem-09-816266-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a4/8777014/e0461a83571e/fchem-09-816266-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a4/8777014/6969da9db690/fchem-09-816266-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a4/8777014/56bccf18e0d5/fchem-09-816266-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a4/8777014/a0fbde7092a4/fchem-09-816266-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a4/8777014/4605606ce051/fchem-09-816266-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a4/8777014/bb08f0ff3897/fchem-09-816266-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a4/8777014/7e2951bc126b/fchem-09-816266-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a4/8777014/0d33b453ffbc/fchem-09-816266-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a4/8777014/568ceb2caa54/fchem-09-816266-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a4/8777014/1c658651c16e/fchem-09-816266-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a4/8777014/17a282806d9d/fchem-09-816266-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a4/8777014/e0461a83571e/fchem-09-816266-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a4/8777014/6969da9db690/fchem-09-816266-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a4/8777014/56bccf18e0d5/fchem-09-816266-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a4/8777014/a0fbde7092a4/fchem-09-816266-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a4/8777014/4605606ce051/fchem-09-816266-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a4/8777014/bb08f0ff3897/fchem-09-816266-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a4/8777014/7e2951bc126b/fchem-09-816266-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a4/8777014/0d33b453ffbc/fchem-09-816266-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a4/8777014/568ceb2caa54/fchem-09-816266-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a4/8777014/1c658651c16e/fchem-09-816266-g011.jpg

相似文献

1
Facing Diseases Caused by Trypanosomatid Parasites: Rational Design of Pd and Pt Complexes With Bioactive Ligands.面对锥虫寄生虫引起的疾病:具有生物活性配体的钯和铂配合物的合理设计。
Front Chem. 2022 Jan 7;9:816266. doi: 10.3389/fchem.2021.816266. eCollection 2021.
2
New Pd-Fe ferrocenyl antiparasitic compounds with bioactive 8-hydroxyquinoline ligands: a comparative study with their Pt-Fe analogues.新型 Pd-Fe 二茂铁类抗寄生虫化合物与具有生物活性的 8-羟基喹啉配体:与它们的 Pt-Fe 类似物的比较研究。
Dalton Trans. 2021 Feb 7;50(5):1651-1665. doi: 10.1039/d0dt03963b. Epub 2021 Jan 15.
3
Multifunctional Organometallic Compounds Active against Infective Trypanosomes: Ru(II) Ferrocenyl Derivatives with Two Different Bioactive Ligands.多功能金属有机化合物抗传染性锥虫:具有两种不同生物活性配体的 Ru(II)二茂铁衍生物。
Inorg Chem. 2024 Jun 24;63(25):11667-11687. doi: 10.1021/acs.inorgchem.4c01125. Epub 2024 Jun 11.
4
Organometallic compounds in the discovery of new agents against kinetoplastid-caused diseases.有机金属化合物在发现针对动质体疾病的新药物中的作用。
Eur J Med Chem. 2018 Jul 15;155:459-482. doi: 10.1016/j.ejmech.2018.05.044. Epub 2018 Jun 1.
5
Metal Compounds in the Development of Antiparasitic Agents: Rational Design from Basic Chemistry to the Clinic.抗寄生虫药物开发中的金属化合物:从基础化学到临床的合理设计
Met Ions Life Sci. 2019 Jan 14;19. doi: 10.1515/9783110527872-019.
6
New multifunctional Ru(II) organometallic compounds show activity against Trypanosoma brucei and Leishmania infantum.新型多功能钌(II)金属有机化合物对布氏锥虫和婴儿利什曼原虫具有活性。
J Inorg Biochem. 2022 Dec;237:112016. doi: 10.1016/j.jinorgbio.2022.112016. Epub 2022 Oct 3.
7
An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases.针对动基体原生动物感染的基于靶点的药物设计概述:人类非洲锥虫病、恰加斯病和利什曼病
Molecules. 2021 Jul 30;26(15):4629. doi: 10.3390/molecules26154629.
8
Metallodrugs for the Treatment of Trypanosomatid Diseases: Recent Advances and New Insights.金属药物治疗原生动物病:最新进展和新见解。
Curr Pharm Des. 2021;27(15):1763-1789. doi: 10.2174/1381612826666201113104633.
9
Antiparasitic chemotherapy: tinkering with the purine salvage pathway.抗寄生虫化疗:对嘌呤补救途径的微调。
Adv Exp Med Biol. 2008;625:116-32. doi: 10.1007/978-0-387-77570-8_10.
10
New heterobimetallic ferrocenyl derivatives are promising antitrypanosomal agents.新型杂双核二茂铁衍生物是很有前途的抗锥虫药物。
Dalton Trans. 2019 Jun 14;48(22):7644-7658. doi: 10.1039/c9dt01317b. Epub 2019 May 3.

引用本文的文献

1
Special Issue: "Rational Design and Synthesis of Bioactive Molecules".特刊:“生物活性分子的合理设计与合成”
Int J Mol Sci. 2024 Sep 14;25(18):9927. doi: 10.3390/ijms25189927.
2
Metallomics: An Essential Tool for the Study of Potential Antiparasitic Metallodrugs.金属组学:研究潜在抗寄生虫金属药物的重要工具。
ACS Omega. 2024 Mar 25;9(14):15744-15752. doi: 10.1021/acsomega.3c10200. eCollection 2024 Apr 9.
3
A novel palladium complex with a coumarin-thiosemicarbazone hybrid ligand inhibits Trypanosoma cruzi release from host cells and lowers the parasitemia in vivo.

本文引用的文献

1
An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases.针对动基体原生动物感染的基于靶点的药物设计概述:人类非洲锥虫病、恰加斯病和利什曼病
Molecules. 2021 Jul 30;26(15):4629. doi: 10.3390/molecules26154629.
2
Platinum and Palladium Complexes as Promising Sources for Antitumor Treatments.铂和钯配合物作为抗肿瘤治疗的有前途的来源。
Int J Mol Sci. 2021 Jul 31;22(15):8271. doi: 10.3390/ijms22158271.
3
Recent developments of metal-based compounds against fungal pathogens.
一种新型钯配合物,具有香豆素-缩氨基硫脲混合配体,可抑制克氏锥虫从宿主细胞中释放,并降低体内寄生虫血症。
J Biol Inorg Chem. 2023 Dec;28(8):711-723. doi: 10.1007/s00775-023-02020-2. Epub 2023 Sep 28.
4
5-Nitrofuryl-Containing Thiosemicarbazone Gold(I) Compounds: Synthesis, Stability Studies, and Anticancer Activity.含 5-硝基呋喃基缩硫代氨基脲的金(I)配合物的合成、稳定性研究及抗癌活性。
Chempluschem. 2023 Dec;88(12):e202300115. doi: 10.1002/cplu.202300115. Epub 2023 May 16.
金属基化合物抗真菌病原体的最新研究进展。
Chem Soc Rev. 2021 Sep 20;50(18):10346-10402. doi: 10.1039/d0cs00945h.
4
The quest of the best - A SAR study of trithiolato-bridged dinuclear Ruthenium(II)-Arene compounds presenting antiparasitic properties.探索最佳:具有抗寄生虫性能的三硫醇桥联双核钌(II)-芳烃配合物的 SAR 研究。
Eur J Med Chem. 2021 Oct 15;222:113610. doi: 10.1016/j.ejmech.2021.113610. Epub 2021 Jun 8.
5
Metallodrugs are unique: opportunities and challenges of discovery and development.金属药物独具特色:发现与开发的机遇与挑战
Chem Sci. 2020 Nov 12;11(48):12888-12917. doi: 10.1039/d0sc04082g.
6
Strategies for the Improvement of Metal-Based Chemotherapeutic Treatments.改善金属基化疗治疗的策略。
Biomedicines. 2021 May 4;9(5):504. doi: 10.3390/biomedicines9050504.
7
Metal Complexes as Antiviral Agents for SARS-CoV-2.金属配合物作为 SARS-CoV-2 的抗病毒药物。
Chembiochem. 2021 Aug 17;22(16):2600-2607. doi: 10.1002/cbic.202100186. Epub 2021 Jun 14.
8
An Overview on the Therapeutics of Neglected Infectious Diseases-Leishmaniasis and Chagas Diseases.被忽视的传染病——利什曼病和恰加斯病的治疗概述
Front Chem. 2021 Mar 12;9:622286. doi: 10.3389/fchem.2021.622286. eCollection 2021.
9
Unveiling the Potential of Transition Metal Complexes for Medicine: Translational in Situ Activation of Metal-Based Drugs from Bench to in Vivo Applications.揭示过渡金属配合物在医学中的潜力:从实验室到体内应用的基于金属药物的转化原位激活。
Chembiochem. 2021 May 14;22(10):1740-1742. doi: 10.1002/cbic.202100015. Epub 2021 Feb 25.
10
New Pd-Fe ferrocenyl antiparasitic compounds with bioactive 8-hydroxyquinoline ligands: a comparative study with their Pt-Fe analogues.新型 Pd-Fe 二茂铁类抗寄生虫化合物与具有生物活性的 8-羟基喹啉配体:与它们的 Pt-Fe 类似物的比较研究。
Dalton Trans. 2021 Feb 7;50(5):1651-1665. doi: 10.1039/d0dt03963b. Epub 2021 Jan 15.